Encyclopedia of Cancer, 1st Edition

  • Published By:
  • ISBN-10: 0080547885
  • ISBN-13: 9780080547886
  • DDC: 616.99
  • Grade Level Range: College Freshman - College Senior
  • 2236 Pages | eBook
  • Original Copyright 2002 | Published/Released November 2007
  • This publication's content originally published in print form: 2002

  • Price:  Sign in for price



Cancer is a group of diseases characterized by uncontrolled cell growth and spread of abnormal cells. Over 150 types of cancer, all with different behaviors and causes, have been classified in humans. Current research has amassed a large body of knowledge about the disease; however, the precise mechanism or group of mechanisms involved in the onset of cancer still eludes researchers. While a variety of treatment options exist, science has yet to uncover a definitive cure.

Since the publication of the first edition of the Encyclopedia of Cancer, an amazing amount of new information has been disseminated in the field of cancer research. This second edition strives to capture the advances occurring in the etiology, prevention, and treatment of cancer, from basic science to clinical application. By providing concise expositions on a broad range of topics, this encyclopedia is an excellent resource for those seeking information beyond their specific areas of expertise. Written by a distinguished panel of authors, entries cover such subjects as oncology, immunology, epidemiology, gene therapy, oncogenes/tumor suppressor genes and pharmacology. This outstanding reference is essential for anyone involved in the study or treatment of cancer.

Table of Contents

Front Cover.
Half Title Page.
Editorial Advisory Board.
Title Page.
Copyright Page.
Contents by Subject Area.
Guide to the Use of the Encyclopedia.
Acute Lymphoblastic Leukemia in Adults.
Acute Lymphoblastic Leukemia in Children.
Acute Myelocytic Leukemia.
Adeno–Associated Virus: A Vector for High–Efficiency Gene Transduction.
Alkylating Agents.
Animal Models for Colon Cancer Chemoprevention.
Antibodies in the Gene Therapy of Cancer.
Antibody–Toxin and Growth Factor–Toxin Fusion Proteins.
Anti–idiotypic Antibody Vaccines.
Antioxidants: Carcinogenic and Chemopreventive Properties.
Antisense: Medicinal Chemistry.
Antisense Nucleic Acids: Clinical Applications.
Antisense: Progress Toward Gene–Directed Cancer Therapy.
Anti–Vascular Endothelial Growth Factor–Based Angiostatics.
APC (Adenomatous Polyposis Coli) Tumor Suppressor.
Ataxia Telangiectasia Syndrome.
Autocrine and Paracrine Growth Mechanisms in Cancer Progression and Metastasis.
Bcl–2 Family Proteins and the Dysregulation of Programmed Cell Death.
Bladder Cancer: Assessment and Management.
Bladder Cancer: Epidemiology.
Bone Tumors.
Brain and Central Nervous System Cancer.
Brain Cancer and Magnetic Resonance Spectroscopy.
Brain Tumors: Epidemiology and Molecular and Cellular Abnormalities.
Breast Cancer.
Cancer Risk Reduction (Diet/Smoking Cessation/Lifestyle Changes).
Cancer Vaccines: Gene Therapy and Dendritic Cell–Based Vaccines.
Cancer Vaccines: Peptide– and Protein–Based Vaccines.
Carbohydrate–Based Vaccines.
Carcinogen–DNA Adducts.
Carcinogenesis: Role of Reactive Oxygen and Nitrogen Species.
Caspases in Programmed Cell Death.
Cationic Lipid–Mediated Gene Therapy.
Cell Cycle Checkpoints.
Cell Cycle Control.
Cell–Matrix Interactions.
Cell–Mediated Immunity to Cancer.
Cellular Responses to DNA Damage.
Chemical Mutagenesis and Carcinogenesis.
Chemoprevention, Pharmacology of.
Chemoprevention Trials.
Chemotherapy: Synergism and Antagonism.
Chromosome Aberrations.
Chronic Lymphocytic Leukemia.
Chronic Myelogenous Leukemia: Etiology, Incidence, and Clinical Features.
Chronic Myelogenous Leukemia: Prognosis and Current Status of Treatment.
Cisplatin and Related Drugs.
c–mos Protooncogene.
c–myc Protooncogene.